Alliance Pharma plc (APH) - Cash Flow Conversion Efficiency

Latest as of December 2024: 0.099x

Based on the latest financial reports, Alliance Pharma plc (APH) has a cash flow conversion efficiency ratio of 0.099x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX20.47 Million ≈ $2.49K USD) by net assets (GBX207.64 Million ≈ $25.26K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Alliance Pharma plc for the company's overall valuation and market capitalisation.

Alliance Pharma plc - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Alliance Pharma plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Alliance Pharma plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alliance Pharma plc ranked by their cash flow conversion efficiency. Explore APH cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Noram Lithium Corp V:NRM	-0.023x
CASI Pharmaceuticals Inc NASDAQ:CASI	0.029x
Epsium Enterprise Limited Ordinary Shares NASDAQ:EPSM	-0.039x
Invibes Advertising NV PA:ALINV	-0.215x
XTL Biopharmaceuticals Ltd TA:XTLB	-0.055x
Nickel North Exploration Corp V:NNX	-0.101x
Star Fashion Culture Holdings Limited NASDAQ:STFS	-0.103x
Henderson High Income Trust LSE:HHI	0.029x

Annual Cash Flow Conversion Efficiency for Alliance Pharma plc (1999–2024)

The table below shows the annual cash flow conversion efficiency of Alliance Pharma plc from 1999 to 2024. View Alliance Pharma plc (APH) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX207.64 Million ≈ $25.26K	GBX38.72 Million ≈ $4.71K	0.186x	+29.33%
2023-12-31	GBX217.87 Million ≈ $26.51K	GBX31.41 Million ≈ $3.82K	0.144x	+97.75%
2022-12-31	GBX287.66 Million ≈ $35.00K	GBX20.97 Million ≈ $2.55K	0.073x	-46.73%
2021-12-31	GBX282.49 Million ≈ $34.37K	GBX38.66 Million ≈ $4.70K	0.137x	-7.50%
2020-12-31	GBX280.96 Million ≈ $34.18K	GBX41.57 Million ≈ $5.06K	0.148x	+13.44%
2019-12-31	GBX274.18 Million ≈ $33.36K	GBX35.76 Million ≈ $4.35K	0.130x	+48.36%
2018-12-31	GBX252.20 Million ≈ $30.69K	GBX22.17 Million ≈ $2.70K	0.088x	-32.75%
2017-12-31	GBX203.38 Million ≈ $24.75K	GBX26.58 Million ≈ $3.23K	0.131x	+38.44%
2016-12-31	GBX179.26 Million ≈ $21.81K	GBX16.93 Million ≈ $2.06K	0.094x	+92.29%
2015-12-31	GBX162.44 Million ≈ $19.76K	GBX7.98 Million ≈ $970.45	0.049x	-69.58%
2014-12-31	GBX70.78 Million ≈ $8.61K	GBX11.42 Million ≈ $1.39K	0.161x	+4.05%
2013-12-31	GBX64.67 Million ≈ $7.87K	GBX10.03 Million ≈ $1.22K	0.155x	-35.33%
2012-12-31	GBX51.85 Million ≈ $6.31K	GBX12.44 Million ≈ $1.51K	0.240x	+21.38%
2011-12-31	GBX44.13 Million ≈ $5.37K	GBX8.72 Million ≈ $1.06K	0.198x	-52.14%
2010-12-31	GBX36.08 Million ≈ $4.39K	GBX14.89 Million ≈ $1.81K	0.413x	-10.77%
2009-12-31	GBX16.63 Million ≈ $2.02K	GBX7.69 Million ≈ $936.14	0.463x	+55.02%
2008-12-31	GBX8.77 Million ≈ $1.07K	GBX2.62 Million ≈ $318.29	0.298x	+16.83%
2007-12-31	GBX6.67 Million ≈ $811.06	GBX1.70 Million ≈ $207.21	0.255x	+392.87%
2006-12-31	GBX10.43 Million ≈ $1.27K	GBX-910.00K ≈ $-110.72	-0.087x	-281.83%
2005-12-31	GBX7.50 Million ≈ $913.02	GBX360.00K ≈ $43.80	0.048x	+229.42%
2005-02-28	GBX6.83 Million ≈ $830.41	GBX-253.00K ≈ $-30.78	-0.037x	+93.01%
2004-02-29	GBX2.23 Million ≈ $270.72	GBX-1.18 Million ≈ $-143.57	-0.530x	+89.46%
2003-02-28	GBX-194.00K ≈ $-23.60	GBX976.00K ≈ $118.75	-5.031x	-13921.47%
2002-12-31	GBX2.24 Million ≈ $272.16	GBX-80.26K ≈ $-9.77	-0.036x	+97.21%
2002-02-28	GBX538.00K ≈ $65.46	GBX-692.00K ≈ $-84.20	-1.286x	-3926.58%
2001-02-28	GBX595.00K ≈ $72.39	GBX20.00K ≈ $2.43	0.034x	-95.49%
2000-02-29	GBX451.00K ≈ $54.87	GBX336.00K ≈ $40.88	0.745x	-93.85%
1999-02-28	GBX114.00K ≈ $13.87	GBX1.38 Million ≈ $168.03	12.114x	--

About Alliance Pharma plc

LSE:APH UK Drug Manufacturers - Specialty & Generic

Market Cap

$4.26 Million

GBX34.97 Billion GBX

Market Cap Rank

#28982 Global

#511 in UK

Share Price

GBX64.70

Change (1 day)

+0.00%

52-Week Range

GBX64.70 - GBX64.70

All Time High

GBX116.47